MENU
GLSI
AS OF
Dec 3 closing price
Price
$8.41
Change
+$0.41 (+5.12%)
Capitalization
116.52M
83 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
GLSI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Greenwich LifeSciences (GLSI) Earnings Date & Reports

Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences... Show more

A.I. Advisor
published Earnings

GLSI is expected to report earnings to fall 5.56% to -34 cents per share on February 25

Greenwich LifeSciences GLSI Stock Earnings Reports
Q4'25
Est.
$-0.34
Q3'25
Missed
by $0.13
Q2'25
Missed
by $0.06
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.40
The last earnings report on November 10 showed earnings per share of -36 cents, missing the estimate of -23 cents. With 81.89K shares outstanding, the current market capitalization sits at 116.52M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GLSI
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GLSI showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for GLSI
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
3992 Bluebonnet Drive
Phone
+1 832 819-3232
Employees
6
Web
https://www.greenwichlifesciences.com